BHP Billiton’s boss is likely to face calls next week for a massive share buyback when he faces shareholders in Australia after his third straight failure to pull off a major acquisition.
Investment bankers are pitching to advise Symantec on strategic options as some shareholders push to break up the company, but the software maker has not made a decision to hire bankers and remains on track with its own strategy, sources said.
General Motors is in the final stage of talks to sell equity to Chinese partner SAIC as part of its landmark initial public offering, two people familiar with the matter said.
Sanofi-Aventis’ $18.5 billion pursuit of Genzyme may be a foregone conclusion for many healthcare industry executives and bankers, but few rivals likely will copy the hostile bid. Read more industry news at the Reuters Health Summit runs which runs from November 8-11.
Private equity firms are using dividend recaps as protection against deals going bad, just stop dressing them up as something they are not, writes Dan Primack for Fortune.com.